# Dolutegravir and Darunavir Evaluation in Adults Failing Therapy

> **NCT03017872** · PHASE4 · UNKNOWN · sponsor: **Kirby Institute** · enrollment: 831 (actual)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** NRTIs
- **DRUG:** Dolutegravir
- **DRUG:** Darunavir
- **DRUG:** Ritonavir

## Key facts

- **NCT ID:** NCT03017872
- **Lead sponsor:** Kirby Institute
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-11-23
- **Primary completion:** 2022-11-11
- **Final completion:** 2023-10-31
- **Target enrollment:** 831 (ACTUAL)
- **Last updated:** 2023-04-18

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03017872

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03017872, "Dolutegravir and Darunavir Evaluation in Adults Failing Therapy". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT03017872. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*